New oral diabetes drug orforglipron (Foundayo) proves heart-safe in study, meeting cardiovascular safety standards compared to insulin glargine.
Epilepsy genetics is transforming diagnosis in Qatar as researchers, led by Dr. Khaled Zamel, pursue medicine for children, offering tailored care.
FDA sets guidelines for wearable technology to improve clinical trials with digital health measurements.
DLBCL radiotherapy offers strong consolidation after R-CHOP, though experts outline specific limitations for advanced-stage patients in clinical reviews.